Platform
Rewrite → Clear → Measure
One platform, three rails: reprogram malignant behavior, clear senescence, and measure outcomes to guide decisions.
01
Cancer Reprogramming (E‑ON‑001)
Rewrite malignant programs to force re‑differentiation, senescence, and natural apoptosis with safety‑first delivery.
Next: in‑vivo efficacy update (Q2 2026)
02
Senolytics (PCC1)
Selectively clear senescent cells, reduce SASP, and improve multi‑system function.
Next: safety window confirmation (Q3 2026)
03
AgeQuant Diagnostics
Real‑time readouts for aging, inflammation, and environmental toxins at 10× lower cost.
Next: panel expansion + validation (Q2 2026)